Repeat-associated non-ATG translation allows expanded repeat RNA to produce polypeptides without a conventional start codon. This route is central to DPR biology because it connects the abnormal repeat transcript directly to protein production. Studying it helps determine how repeat-derived products arise and provides a mechanistic basis for targeting repeat RNA or the translation process.
Dipeptide repeat proteins can accumulate in both the nucleus and cytoplasm, placing them near processes that govern RNA handling and movement between cellular compartments. Their interactions with RNA-binding proteins and cellular transport machinery are therefore important experimental readouts. Linking localization with disrupted nucleocytoplasmic transport, RNA processing, and protein homeostasis helps explain how intracellular distribution relates to neuronal injury.
Unlike conventional protein translation, which uses a conventional start codon, repeat-associated non-ATG translation can generate DPRs from expanded repeat RNA without that initiating signal. This distinction focuses attention on the repeat sequence and its RNA context rather than only on standard translation initiation. It also explains why repeat RNA itself is considered a potential therapeutic target.
DPR clearance is relevant because these proteins can accumulate in the nucleus and cytoplasm and are associated with disruption of protein homeostasis. Research that examines how DPRs are removed or reduced can therefore address both their intracellular persistence and their potential toxicity. This strategy complements approaches aimed at repeat RNA or the translation process.
A useful workflow should examine DPR production, intracellular localization, molecular interactions, and effects on cellular pathways. Measurements can be organized around repeat-associated translation, accumulation in the nucleus or cytoplasm, interactions with RNA-binding proteins and transport machinery, and disruption of RNA processing or protein homeostasis. Together, these observations connect molecular events with potential neuronal consequences.
In neuroscience, DPR research helps connect C9orf72 repeat expansion biology with mechanisms relevant to amyotrophic lateral sclerosis and frontotemporal dementia. Investigators can use findings about DPR production, localization, and toxicity to guide biomarker development and therapeutic strategies. Candidate approaches may target repeat RNA, repeat-associated translation, or the clearance of accumulated DPRs.